Voluntary Scheme for Branded Medicines Pricing and Access
(asked on 19th April 2023) - View Source
Question to the Department of Health and Social Care:
What recent assessment he has made of the potential impact of changes to the Voluntary Scheme for Branded Medicines Pricing Access rebate on foreign direct investment into the British Pharmaceutical Industry.
This question was answered on 25th April 2023
We have been working directly with industry to understand the impact of changes to VPAS on investments into the UK life sciences sector. We remain firmly committed to VPAS and to working with the pharmaceutical industry to create an environment that facilitates innovation for the development of medicines in the UK.